Luspatercept
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 340 publications
Precision Medicine in Transfusion-Dependent and Non-Transfusion-Dependent β-Thalassemia: Toward Personalized Diagnosis and Therapy.
Journal: Hemoglobin
Published: August 10, 2026
2026 Update on Clinical Trials in β-Thalassemia.
Journal: American journal of hematology
Published: June 11, 2026
Luspatercept and thrombotic events in patients with myelodysplastic syndrome: a target trial emulation framework using TriNetX database.
Journal: Leukemia & lymphoma
Published: June 10, 2026
Pyruvate Kinase Activation in the Management of Thalassemia and Sickle Cell Disease.
Journal: Hemoglobin
Published: June 09, 2026
Erythroferrone in β-thalassemia: Systematic review and meta-analysis.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: May 23, 2026
Luspatercept Induces Significant Improvement in Anemia in Dominant Thalassemia Secondary to Heterozygous STEAP3 and Beta-Thalassemia Trait.
Journal: American journal of hematology
Published: May 14, 2026
Targeted treatment of anemia in myelofibrosis and the impact of JAK inhibitors.
Journal: Expert opinion on pharmacotherapy
Published: May 08, 2026
Outcomes with luspatercept in patients with β-thalassemia: a systematic review and meta-analysis.
Journal: Annals of hematology
Published: April 23, 2026
EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion-Dependent Thalassemia.
Journal: American journal of hematology
Published: April 22, 2026
Luspatercept and imetelstat for myelodysplastic syndrome: updates from ASH 2025 annual meeting.
Journal: Journal of hematology & oncology
Published: April 19, 2026
Last Updated: 09/26/2026